Ledger.Open graph →
SEC Form D · filed May 23, 2017

Kleo Pharmaceuticals, Inc

Offering
—
Sold
$19.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW HAVEN, CT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Declan Doogan · Palm Coast, FLDirectorDavid Spiegel · New Haven, CTExec · DirectorCharles G. Drake · New York, NYDirectorRoy Prieb · New Haven, CTExec · DirectorJohn W. Childs · Waltham, MADirectorTimothy Davenport · Tysons, VADirectorCecelia D. Noreen · Lopez Island, WADirectorJoanne J. Fitzgerald · Luxembourg, LuxembourgExec · DirectorCorson Ellis · Tysons, VADirectorMatthew Boehm · Tysons, VAExec · DirectorJennifer D. Schneider · Mountain View, CADirectorAndrew D. Page · Mountain View, CAExec · DirectorJoe D. Carey · Mountain View, CADirectorErica J. Palsis · Mountain View, CADirectorDave D. Engberg · Mountain View, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗